The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome
Open accessAbstract
Purpose: Patients with Lynch syndrome are at high risk for colon and endometrial cancer, but also at an elevated risk for other less common cancers. The purpose of this retrospective cohort study was to provide risk estimates for these less common cancers in proven carriers of pathogenic mutations in the mismatch repair (MMR) genes MLH1, MSH2, and MSH6. Patients and Methods: Data were pooled from the German and Dutch national Lynch syndrome registries. Seven different cancer types were analyzed: stomach, small bowel, urinary bladder, other urothelial, breast, ovarian, and prostate cancer. Age-, sex- and MMR gene–specific cumulative risks (CRs) were calculated using the Kaplan-Meier method. Sex-specific incidence rates were compared with general population incidence rates by calculating standardized incidence ratios (SIRs). Multivariate Cox regression analysis was used to estimate the impact of sex and mutated gene on cancer risk. Results: The cohort comprised 2,118 MMR gene mutation carriers (MLH1, n = 806; MSH2, n = 1,004; MSH6, n = 308). All cancers were significantly more frequent than in the general population. The highest risks were found for male small bowel cancer (SIR, 251; 95% CI, 177 to 346; CR at 70 years, 12.0; 95% CI, 5.7 to 18.2). Breast cancer showed an SIR of 1.9 (95% CI, 1.4 to 2.4) and a CR of 14.4 (95% CI, 9.5 to 19.3). MSH2 mutation carriers had a considerably higher risk of developing urothelial cancer than MLH1 or MSH6 carriers. Conclusion: The sex- and gene-specific differences of less common cancer risks should be taken into account in cancer surveillance and prevention programs for patients with Lynch syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of the cancer incidence and mortality in Europe in 2006
Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., & Boyle, P. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl498 · Cited by 4,036
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183
Self-citationVASEN, H., WATSON, P., MECKLIN, J., & LYNCH, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70510-x · Cited by 2,519
Self-citationEstimates of cancer incidence and mortality in Europe in 2008
Ferlay, J., Parkin, D. M., & Steliarova-Foucher, E. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.014 · Cited by 2,319
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
Vasen, H. F. A., Mecklin, J. P., Meera Khan, P., & Lynch, H. T. (1991) · Diseases of the Colon & Rectum · doi:10.1007/bf02053699 · Cited by 2,147
Self-citationCancer risk in mutation carriers of DNA-mismatch-repair genes
Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L. A., de la Chapelle, A., Peltom�ki, P., Mecklin, J.-P., & J�rvinen, H. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990412)81:2<214::aid-ijc8>3.0.co;2-l · Cited by 1,278
Rodriguez-Bigas, M. A., Boland, C. R., Hamilton, S. R., Henson, D. E., Srivastava, S., Jass, J. R., Khan, P. M., Lynch, H., Smyrk, T., Perucho, M., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1758 · Cited by 1,137
The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome
Watson, P., Vasen, H. F. A., Mecklin, J., Bernstein, I., Aarnio, M., Järvinen, H. J., Myrhøj, T., Sunde, L., Wijnen, J. T., & Lynch, H. T. (2008) · International Journal of Cancer · doi:10.1002/ijc.23508 · Cited by 596
Self-citationRisk of Pancreatic Cancer in Families With Lynch Syndrome
Kastrinos, F. (2009) · JAMA · doi:10.1001/jama.2009.1529 · Cited by 544
Vasen, H. F. A., Stormorken, A., Menko, F. H., Nagengast, F. M., Kleibeuker, J. H., Griffioen, G., Taal, B. G., Moller, P., & Wijnen, J. T. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.20.4074 · Cited by 406
Self-citationRisks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
Baglietto, L., Lindor, N. M., Dowty, J. G., White, D. M., Wagner, A., Gomez Garcia, E. B., Vriends, A. H. J. T., Dutch Lynch Syndrome Study Group, Cartwright, N. R., Barnetson, R. A., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp473 · Cited by 376
Self-citationBarrow, E., Robinson, L., Alduaij, W., Shenton, A., Clancy, T., Lalloo, F., Hill, J., & Evans, D. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01125.x · Cited by 318
Risk and Epidemiological Time Trends of Gastric Cancer in Lynch Syndrome Carriers in The Netherlands
Capelle, L. G., Van Grieken, N. C. T., Lingsma, H. F., Steyerberg, E. W., Klokman, W. J., Bruno, M. J., Vasen, H. F. A., & Kuipers, E. J. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.051 · Cited by 230
Self-citationScott, R. J., McPhillips, M., Meldrum, C. J., Fitzgerald, P. E., Adams, K., Spigelman, A. D., du Sart, D., Tucker, K., & Kirk, J. (2001) · The American Journal of Human Genetics · doi:10.1086/316942 · Cited by 202
van der Post, R. S., Kiemeney, L. A., Ligtenberg, M. J. L., Witjes, J. A., Hulsbergen-van de Kaa, C. A., Bodmer, D., Schaap, L., Kets, C. M., van Krieken, J. H. J. M., & Hoogerbrugge, N. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2010.076992 · Cited by 197
Self-citationGoecke, T. O., Schulmann, K., Engel, C., Holinski‐Feder, E., Pagenstecher, C., Schackert, H. K., Kloor, M., Kunstmann, E., Vogelsang, H., Keller, G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7333 · Cited by 165
Self-citationScreening for hereditary non-polyposis colorectal cancer: A study of 22 kindreds in The Netherlands
Vasen, H. F. A., Jager, F. C. A. D. H., Menko, F. H., et al. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90296-9 · Cited by 155
Self-citationGerm-Line Mutations in Mismatch Repair Genes Associated with Prostate Cancer
Grindedal, E. M., Møller, P., Eeles, R. A., Stormorken, A. T., Lothe, I. M. B., Landrø, S. M., Clark, N., Kvåle, R., Shanley, S., & Mæhle, L. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0058 · Cited by 113
Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis
Chao, E., & Lipkin, S. M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj489 · Cited by 103
Watson, P. A., Ashwathnarayan, R., Lynch, H. T., & Roy, H. K. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.22.2429 · Cited by 88
Review article: the Lynch syndrome (hereditary nonpolyposis colorectal cancer)*
Vasen, H. F. A. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03479.x · Cited by 86
Self-citationIs surveillance of the small bowel indicated for Lynch syndrome families?
ten Kate, G. L., Kleibeuker, J. H., Nagengast, F. M., Craanen, M. E., Cats, A., Menko, F. H., & Vasen, H. F. A. (2007) · Gut · doi:10.1136/gut.2006.118299 · Cited by 86
Self-citationPande, M., Lynch, P. M., Hopper, J. L., Jenkins, M. A., Gallinger, S., Haile, R. W., Marchand, L. L., Lindor, N. M., Campbell, P. T., Newcomb, P. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1877 · Cited by 82
Diergaarde, B. B., Braam, H., Vasen, H. F. A., Nagengast, F. M., van Muijen, G. N. P., Kok, F. J., & Kampman, E. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.02.019 · Cited by 75
Self-citationBotma, A., Nagengast, F. M., Braem, M. G. M., Hendriks, J. C. M., Kleibeuker, J. H., Vasen, H. F. A., & Kampman, E. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.0453 · Cited by 73
Self-citationSmoking Increases the Risk for Colorectal Adenomas in Patients With Lynch Syndrome
Winkels, R. M., Botma, A., van Duijnhoven, F. J. B., Nagengast, F. M., Kleibeuker, J. H., Vasen, H. F. A., & Kampman, E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.10.033 · Cited by 53
Self-citationBonadona, V., Bonaïti, B., Olschwang, S., Grandjouan, S., Wang, Q., Bonaïti‐Pellié, C., & Lasset, C. (2011) · HAL · Cited by 36
Cited by
Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., & Burt, R. W. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.435 · Cited by 1,662
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Matulonis, U. A., Sood, A. K., Fallowfield, L., Howitt, B. E., Sehouli, J., & Karlan, B. Y. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.61 · Cited by 1,362
Vasen, H. F. A., Blanco, I., Aktan-Collan, K., Gopie, J. P., Alonso, A., Aretz, S., Bernstein, I., Bertario, L., Burn, J., Capella, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304356 · Cited by 746
Self-citationDominguez-Valentin, M., Sampson, J. R., Seppälä, T. T., ten Broeke, S. W., Plazzer, J.-P., Nakken, S., Engel, C., Aretz, S., Jenkins, M. A., Sunde, L., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-019-0596-9 · Cited by 662
Self-citation
Metadata
- Authors
- Engel, C., Loeffler, M., Steinke, V., Rahner, N., Holinski-Feder, E., Dietmaier, W., Schackert, H. K., Goergens, H., von Knebel Doeberitz, M., Goecke, T. O., Schmiegel, W., Buettner, R., Moeslein, G., Letteboer, T. G. W., García, E. G., Hes, F. J., Hoogerbrugge, N., Menko, F. H., van Os, T. A. M., Sijmons, R. H., Wagner, A., Kluijt, I., Propping, P., & Vasen, H. F. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2012-12-10
- Volume
- 30
- Issue
- 35
- Pages
- 4409-4415
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2129567712
- Cited by
- 306
- References
- 28
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.